RET Regulates Human Medullary Thyroid Cancer Cell Proliferation through CDK5 and STAT3 Activation
Medullary thyroid cancer (MTC) is a neuroendocrine tumor that arises from the parafollicular C-cells, which produces the hormone calcitonin. RET is a transmembrane receptor protein-tyrosine kinase, which is highly expressed in MTC. Our previous studies reported that cyclin-dependent kinase 5 (CDK5)...
Main Authors: | Chia-Herng Yue, Muhammet Oner, Chih-Yuan Chiu, Mei-Chih Chen, Chieh-Lin Teng, Hsin-Yi Wang, Jer-Tsong Hsieh, Chih-Ho Lai, Ho Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/11/6/860 |
Similar Items
-
Adefovir Dipivoxil as a Therapeutic Candidate for Medullary Thyroid Carcinoma: Targeting RET and STAT3 Proto-Oncogenes
by: Tariq Alqahtani, et al.
Published: (2023-04-01) -
Molecular Basis of Medullary Thyroid Carcinoma: The Role of RET Polymorphisms
by: Ana Luiza Maia, et al.
Published: (2011-12-01) -
RET splice site variants in medullary thyroid carcinoma
by: Daryoush Saeed-Vafa, et al.
Published: (2024-03-01) -
Selective Antitumor Activity of Datelliptium toward Medullary Thyroid Carcinoma by Downregulating RET Transcriptional Activity
by: Tariq Alqahtani, et al.
Published: (2021-06-01) -
Modifier Role of Common <i>RET</i> Variants in Sporadic Medullary Thyroid Carcinoma
by: Anna Skalniak, et al.
Published: (2021-10-01)